Ru-Fang Yeh
Overview
Explore the profile of Ru-Fang Yeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
3964
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Takeuchi J, Lou X, Alexander J, Sugizaki H, Delgado-Olguin P, Holloway A, et al.
Nat Commun
. 2011 Feb;
2:187.
PMID: 21304516
Dominant mutations in cardiac transcription factor genes cause human inherited congenital heart defects (CHDs); however, their molecular basis is not understood. Interactions between transcription factors and the Brg1/Brm-associated factor (BAF)...
12.
Punnoose E, Atwal S, Spoerke J, Savage H, Pandita A, Yeh R, et al.
PLoS One
. 2010 Sep;
5(9):e12517.
PMID: 20838621
Background: Evaluation of cancer biomarkers from blood could significantly enable biomarker assessment by providing a relatively non-invasive source of representative tumor material. Circulating Tumor Cells (CTCs) isolated from blood of...
13.
Diakos C, Zhong S, Xiao Y, Zhou M, Vasconcelos G, Krapf G, et al.
Blood
. 2010 Sep;
116(23):4885-93.
PMID: 20807887
There is increasing evidence that miRNA and transcription factors interact in an instructive fashion in normal and malignant hematopoiesis. We explored the impact of TEL-AML1 (ETV6-RUNX1), the most common fusion...
14.
Dornan D, Spleiss O, Yeh R, Duchateau-Nguyen G, Dufour A, Zhi J, et al.
Blood
. 2010 Aug;
116(20):4212-22.
PMID: 20705761
Polymorphisms of activating Fc-γ receptors (FCGRs) on natural killer cells and macrophages result in variable affinity for immunoglobulin G1 monoclonal antibodies and subsequently modulate antibody-dependent cellular cytotoxicity (ADCC) activity. Whether...
15.
Barajas Jr R, Hodgson J, Chang J, VandenBerg S, Yeh R, Parsa A, et al.
Radiology
. 2010 Jan;
254(2):564-76.
PMID: 20093527
Purpose: To determine whether magnetic resonance (MR) imaging is influenced by genetic and cellular features of glioblastoma multiforme (GBM) aggressiveness. Materials And Methods: In this HIPAA-compliant institutional review board-approved study,...
16.
Christensen B, Houseman E, Marsit C, Zheng S, Wrensch M, Wiemels J, et al.
PLoS Genet
. 2009 Aug;
5(8):e1000602.
PMID: 19680444
Epigenetic control of gene transcription is critical for normal human development and cellular differentiation. While alterations of epigenetic marks such as DNA methylation have been linked to cancers and many...
17.
Christensen B, Marsit C, Houseman E, Godleski J, Longacker J, Zheng S, et al.
Cancer Res
. 2009 Jul;
69(15):6315-21.
PMID: 19638575
Pathologic differentiation of tissue of origin in tumors found in the lung can be challenging, with differentiation of mesothelioma and lung adenocarcinoma emblematic of this problem. Indeed, proper classification is...
18.
Wrensch M, Jenkins R, Chang J, Yeh R, Xiao Y, Decker P, et al.
Nat Genet
. 2009 Jul;
41(8):905-8.
PMID: 19578366
The causes of glioblastoma and other gliomas remain obscure. To discover new candidate genes influencing glioma susceptibility, we conducted a principal component-adjusted genome-wide association study (GWAS) of 275,895 autosomal variants...
19.
Hodgson J, Yeh R, Ray A, Wang N, Smirnov I, Yu M, et al.
Neuro Oncol
. 2009 Jan;
11(5):477-87.
PMID: 19139420
Development of model systems that recapitulate the molecular heterogeneity observed among glioblastoma multiforme (GBM) tumors will expedite the testing of targeted molecular therapeutic strategies for GBM treatment. In this study,...
20.
Marsit C, Christensen B, Houseman E, Karagas M, Wrensch M, Yeh R, et al.
Carcinogenesis
. 2009 Jan;
30(3):416-22.
PMID: 19126652
Head and neck squamous cell carcinomas (HNSCCs) represent clinically and etiologically heterogeneous tumors affecting >40 000 patients per year in the USA. Previous research has identified individual epigenetic alterations and,...